// App-Quantinova.ai

9514 : Derivation and validation of a prediction scale for response to PD-1 monotherapy.

Researchers

Presenter

  • Adi Nosrati

Principal Investigators

  • Simone M. Goldinger

  • Katy K. Tsai

  • Kimberly Loo

  • Paul Tumeh

  • Omid Hamid

  • Alain Patrick Algazi

  • Mitchell P. Levesque

  • Reinhard Dummer

  • Adil Daud

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • UC San Francisco, San Francisco, CA

  • UCLA, Los Angeles, CA

  • The Angeles Clinic and Research Institute, Los Angeles, CA

  • University of California, San Francisco, San Francisco, CA

  • University Hospital of Zurich, Zurich, Switzerland

Locations

  • United States

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved